Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Amyloidosis × Melphalan × Clear all

Phase

Status

Sponsor Class

OTHER 6 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 11 Lymphoma 7 Neuroblastoma 6 Neoplasms, Plasma Cell 5 Immunoglobulin Light-chain Amyloidosis 4 Hodgkin Disease 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Leukemia, Myeloid, Acute 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Biphenotypic, Acute 3 Leukemia 3 Ganglioneuroblastoma 3 Waldenstrom Macroglobulinemia 2 Sarcoma, Ewing 2 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Lymphoproliferative Disorders 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Lymphatic Diseases 2 Leukemia, Myeloid 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphoid 2 Leukemia, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hematologic Diseases 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01277016 2017-03-10

EMN-03

European Myeloma Network B.V.

Phase 3 Completed

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡